CYCN - Cyclerion Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5267.99M
Enterprise Value 3267.99M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.34

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -114.74M
Net Income Avi to Common (ttm)-127.35M
Diluted EPS (ttm)-4.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.28

Cash Flow Statement

Operating Cash Flow (ttm)-105.34M
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 34.25%
52 Week High 322.85
52 Week Low 39.10
50-Day Moving Average 313.75
200-Day Moving Average 315.22

Share Statistics

Avg Vol (3 month) 3171.08k
Avg Vol (10 day) 3211.01k
Shares Outstanding 527.4M
Float 24.94M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (May 31, 2019) 41.47M
Short Ratio (May 31, 2019) 410.74
Short % of Float (May 31, 2019) 45.92%
Short % of Shares Outstanding (May 31, 2019) 45.35%
Shares Short (prior month Apr 30, 2019) 41.36M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A